Return On Assets of Citius Pharmaceuticals, Inc. from 31 Mar 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Citius Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 30 Jun 2024.
  • Citius Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Jun 2024 was -20%, a 27% increase year-over-year.
  • Citius Pharmaceuticals, Inc. annual Return On Assets for 2023 was -30%, a 12% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Return On Assets for 2022 was -27%, a 34% decline from 2021.
  • Citius Pharmaceuticals, Inc. annual Return On Assets for 2021 was -20%, a 62% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Citius Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -20% +7.4% +27% 01 Apr 2024 30 Jun 2024
Q1 2024 -18% +9.9% +36% 01 Jan 2024 31 Mar 2024
Q4 2023 -19% +4.7% +20% 01 Oct 2023 31 Dec 2023
Q3 2023 -30% -3.3% -12% 01 Jul 2023 30 Sep 2023
Q2 2023 -28% -4.6% -20% 01 Apr 2023 30 Jun 2023
Q1 2023 -28% -7.6% -38% 01 Jan 2023 31 Mar 2023
Q4 2022 -24% -6.4% -37% 01 Oct 2022 31 Dec 2022
Q3 2022 -27% -6.8% -34% 01 Jul 2022 30 Sep 2022
Q2 2022 -23% +1.5% +6% 01 Apr 2022 30 Jun 2022
Q1 2022 -20% +14% +40% 01 Jan 2022 31 Mar 2022
Q4 2021 -17% +42% +71% 01 Oct 2021 31 Dec 2021
Q3 2021 -20% +32% +62% 01 Jul 2021 30 Sep 2021
Q2 2021 -25% +29% +54% 01 Apr 2021 30 Jun 2021
Q1 2021 -33% +26% +43% 01 Jan 2021 31 Mar 2021
Q4 2020 -59% -2% -3.4% 01 Oct 2020 31 Dec 2020
Q3 2020 -53% +1.8% +3.3% 01 Jul 2020 30 Sep 2020
Q2 2020 -54% +0.26% +0.48% 01 Apr 2020 30 Jun 2020
Q1 2020 -59% -13% -28% 01 Jan 2020 31 Mar 2020
Q4 2019 -57% -9.1% -19% 01 Oct 2019 31 Dec 2019
Q3 2019 -54% -8.5% -19% 01 Jul 2019 30 Sep 2019
Q2 2019 -54% -4.6% -9.4% 01 Apr 2019 30 Jun 2019
Q1 2019 -46% +6.1% +12% 01 Jan 2019 31 Mar 2019
Q4 2018 -48% -0.47% -0.98% 01 Oct 2018 31 Dec 2018
Q3 2018 -46% +0.95% +2% 01 Jul 2018 30 Sep 2018
Q2 2018 -50% -3.5% -7.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -52% -1.6% -3.1% 01 Jan 2018 31 Mar 2018
Q4 2017 -48% -7.3% -18% 01 Oct 2017 31 Dec 2017
Q3 2017 -47% +0.56% +1.2% 01 Jul 2017 30 Sep 2017
Q2 2017 -46% +8.1% +15% 01 Apr 2017 30 Jun 2017
Q1 2017 -51% +6.3% +11% 01 Jan 2017 31 Mar 2017
Q4 2016 -41% +428% +91% 01 Oct 2016 31 Dec 2016
Q3 2016 -47% +305% +87% 01 Jul 2016 30 Sep 2016
Q2 2016 -54% +148% +73% 01 Apr 2016 30 Jun 2016
Q1 2016 -57% +106% +65% 01 Jan 2016 31 Mar 2016
Q4 2015 -469% -296% -171% 01 Oct 2015 31 Dec 2015
Q3 2015 -353% -175% -99% 01 Jul 2015 30 Sep 2015
Q2 2015 -202% 01 Apr 2015 30 Jun 2015
Q1 2015 -163% 01 Jan 2015 31 Mar 2015
Q4 2014 -173% 01 Oct 2014 31 Dec 2014
Q3 2014 -177% 01 Jul 2014 30 Sep 2014
Q2 2012 -12579%* 01 Apr 2012 30 Jun 2012
Q1 2012 -15569% 01 Jan 2012 31 Mar 2012

Citius Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -30% -3.3% -12% 01 Oct 2022 30 Sep 2023
2022 -27% -6.8% -34% 01 Oct 2021 30 Sep 2022
2021 -20% +32% +62% 01 Oct 2020 30 Sep 2021
2020 -53% +1.8% +3.3% 01 Oct 2019 30 Sep 2020
2019 -54% -8.5% -19% 01 Oct 2018 30 Sep 2019
2018 -46% +0.95% +2% 01 Oct 2017 30 Sep 2018
2017 -47% +0.56% +1.2% 01 Oct 2016 30 Sep 2017
2016 -47% +305% +87% 01 Oct 2015 30 Sep 2016
2015 -353% -175% -99% 01 Oct 2014 30 Sep 2015
2014 -177% +4591% +96% 01 Oct 2013 30 Sep 2014
2013 -4768% +989948% +100% 01 Jan 2013 31 Dec 2013
2012 -994716% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.